CL2015003507A1 - Beta-caseína a2 y prevención de inflamación del intestino - Google Patents
Beta-caseína a2 y prevención de inflamación del intestinoInfo
- Publication number
- CL2015003507A1 CL2015003507A1 CL2015003507A CL2015003507A CL2015003507A1 CL 2015003507 A1 CL2015003507 A1 CL 2015003507A1 CL 2015003507 A CL2015003507 A CL 2015003507A CL 2015003507 A CL2015003507 A CL 2015003507A CL 2015003507 A1 CL2015003507 A1 CL 2015003507A1
- Authority
- CL
- Chile
- Prior art keywords
- beta
- casein
- bowel inflammation
- inflammation prevention
- prevention
- Prior art date
Links
- 230000002265 prevention Effects 0.000 title abstract 2
- 102000011632 Caseins Human genes 0.000 title 1
- 108010076119 Caseins Proteins 0.000 title 1
- 230000008993 bowel inflammation Effects 0.000 title 1
- 235000021247 β-casein Nutrition 0.000 title 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 210000000936 intestine Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Marine Sciences & Fisheries (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Animal Husbandry (AREA)
- Mycology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Dairy Products (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Confectionery (AREA)
- Fodder In General (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361829764P | 2013-05-31 | 2013-05-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2015003507A1 true CL2015003507A1 (es) | 2016-12-16 |
Family
ID=51989162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2015003507A CL2015003507A1 (es) | 2013-05-31 | 2015-11-30 | Beta-caseína a2 y prevención de inflamación del intestino |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US20160113997A1 (enExample) |
| EP (2) | EP3003485B1 (enExample) |
| JP (2) | JP6867158B2 (enExample) |
| KR (2) | KR102282972B1 (enExample) |
| CN (2) | CN112316116A (enExample) |
| AU (2) | AU2014271423B2 (enExample) |
| BR (1) | BR112015029987A8 (enExample) |
| CA (1) | CA2913890C (enExample) |
| CL (1) | CL2015003507A1 (enExample) |
| DK (1) | DK3003485T3 (enExample) |
| ES (1) | ES2742306T3 (enExample) |
| IL (2) | IL242833B (enExample) |
| MX (2) | MX367794B (enExample) |
| MY (1) | MY179497A (enExample) |
| PH (2) | PH12015502674B1 (enExample) |
| RU (1) | RU2669553C2 (enExample) |
| SG (2) | SG11201509769QA (enExample) |
| WO (1) | WO2014193248A1 (enExample) |
| ZA (1) | ZA201508983B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112316116A (zh) * | 2013-05-31 | 2021-02-05 | 艾尔牛奶有限公司 | β-酪蛋白A2和肠炎症的预防 |
| AU2014287862B2 (en) * | 2013-07-12 | 2019-07-11 | The A2 Milk Company Limited | Beta-casein A2 and reducing or preventing symptoms of lactose intolerance |
| GB2519101A (en) * | 2013-10-09 | 2015-04-15 | Nicoventures Holdings Ltd | Electronic vapour provision system |
| CN106455662A (zh) * | 2014-06-03 | 2017-02-22 | 雅培制药有限公司 | 包含亲脂性活性成分的营养组合物 |
| MX392728B (es) * | 2015-05-22 | 2025-03-24 | A2 Milk Co Ltd | Beta-caseina a2 y su capacidad antioxidante. |
| WO2017003300A1 (en) * | 2015-06-29 | 2017-01-05 | The A2 Milk Company Limited | A2 beta-casein and viscosity of milk products |
| WO2017171563A1 (en) | 2016-03-30 | 2017-10-05 | The A2 Milk Company Limited | Beta-caseins and cognitive function |
| WO2018063008A1 (en) * | 2016-09-30 | 2018-04-05 | The A2 Milk Company Limited | Beta-caseins and gut microbiota |
| EP3526201B1 (en) * | 2016-10-14 | 2020-11-18 | H. Hoffnabb-La Roche Ag | Imidazole compounds as eaat3 inhibitors |
| NL2019906B1 (en) * | 2017-11-14 | 2019-05-20 | Ausnutria Hyproca B V | Composition comprising a2 b-casein and a vegetable fat mixture |
| CN112205476A (zh) * | 2019-07-11 | 2021-01-12 | 北京三元食品股份有限公司 | β-酪蛋白A2、其组合物在促进双歧杆菌属增殖中的应用 |
| WO2021003741A1 (zh) * | 2019-07-11 | 2021-01-14 | 北京三元食品股份有限公司 | β-酪蛋白A2、其组合物在促进双歧杆菌属增殖中的应用 |
| CN115708530B (zh) * | 2022-11-15 | 2024-08-09 | 北大荒完达山乳业股份有限公司 | 一种促进消化舒适性并稳定血糖的孕产妇配方奶粉及其制备方法 |
| CN117322467A (zh) * | 2023-10-11 | 2024-01-02 | 东北农业大学 | A2β-酪蛋白在制备功能性食品中的应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE442585T1 (de) | 1994-11-04 | 2009-09-15 | A2 Corp Ltd | Selektionsverfahren für nicht-diabetogene milch oder milchprodukte sowie hierdurch erfasste milch oder milchprodukte |
| NZ306584A (en) * | 1995-05-16 | 2000-02-28 | Corran Norman Stuart Mclachlan | Milk or dairy products derived from animals and which are free of beta casein |
| WO1996036239A1 (en) | 1995-05-16 | 1996-11-21 | Corran Norman Stuart Mclachlan | Food product and process |
| US6570060B2 (en) | 1995-05-16 | 2003-05-27 | Mclachlan Corran Norman Stuart | Milk lacking β-casein A1 |
| AU4266100A (en) * | 1995-05-16 | 2000-10-12 | Corran Norman Stuart Mclachlan | Food product and process |
| EP1196047A4 (en) * | 1999-06-29 | 2004-12-22 | New Zealand Milk Inst Ltd | MILK-BASED PROPHYLACTIC FOOD SUPPLEMENTS |
| NZ516712A (en) * | 1999-06-29 | 2003-10-31 | New Zealand Milk Inst Ltd | Prophylactic dietary supplement based on milk |
| AU9037401A (en) | 2000-09-08 | 2002-03-22 | New Zealand Dairy Board | Milk containing beta-casein with proline at position 67 does not aggravate neurological disorders |
| CA2444470A1 (en) * | 2001-04-10 | 2002-10-24 | Societe Des Produits Nestle S.A. | Method and composition for prophylaxis of diabetes |
| US20060280802A1 (en) * | 2002-10-04 | 2006-12-14 | Campbell Julie H | Therapeutic uses of beta-casein a2 and dietary supplement containing beta-casein a2 |
| US7481127B2 (en) | 2004-09-27 | 2009-01-27 | Lester William T | Continuously variable transmission using oscillating torque and one-way drives |
| KR20090083363A (ko) * | 2006-10-06 | 2009-08-03 | 케리 그룹 서비스 인터내셔날 리미티드 | 우유 단백질 조성물 및 그 용도 |
| US8871276B2 (en) * | 2008-02-11 | 2014-10-28 | Technion Research And Development Foundation Ltd. | Beta-casein assemblies for mucosal delivery of therapeutic bioactive agents |
| TWI516269B (zh) * | 2009-08-14 | 2016-01-11 | 禾伸堂生技股份有限公司 | 使用於炎症性腸疾病（ｉｂｄ）治療和預防之透明質酸混合物 |
| CN112316116A (zh) * | 2013-05-31 | 2021-02-05 | 艾尔牛奶有限公司 | β-酪蛋白A2和肠炎症的预防 |
| AU2014287862B2 (en) * | 2013-07-12 | 2019-07-11 | The A2 Milk Company Limited | Beta-casein A2 and reducing or preventing symptoms of lactose intolerance |
-
2014
- 2014-05-30 CN CN202011164629.1A patent/CN112316116A/zh active Pending
- 2014-05-30 AU AU2014271423A patent/AU2014271423B2/en active Active
- 2014-05-30 EP EP14804528.9A patent/EP3003485B1/en not_active Revoked
- 2014-05-30 MX MX2015016493A patent/MX367794B/es active IP Right Grant
- 2014-05-30 KR KR1020157036746A patent/KR102282972B1/ko active Active
- 2014-05-30 MX MX2019010594A patent/MX391963B/es unknown
- 2014-05-30 CN CN201480042721.7A patent/CN105407971B/zh active Active
- 2014-05-30 CA CA2913890A patent/CA2913890C/en active Active
- 2014-05-30 EP EP19169044.5A patent/EP3542813A1/en not_active Withdrawn
- 2014-05-30 MY MYPI2015704353A patent/MY179497A/en unknown
- 2014-05-30 SG SG11201509769QA patent/SG11201509769QA/en unknown
- 2014-05-30 DK DK14804528.9T patent/DK3003485T3/da active
- 2014-05-30 KR KR1020217023199A patent/KR102402455B1/ko active Active
- 2014-05-30 ES ES14804528T patent/ES2742306T3/es active Active
- 2014-05-30 US US14/894,711 patent/US20160113997A1/en not_active Abandoned
- 2014-05-30 SG SG10201709509RA patent/SG10201709509RA/en unknown
- 2014-05-30 RU RU2015153113A patent/RU2669553C2/ru active
- 2014-05-30 JP JP2016516476A patent/JP6867158B2/ja active Active
- 2014-05-30 WO PCT/NZ2014/000102 patent/WO2014193248A1/en not_active Ceased
- 2014-05-30 BR BR112015029987A patent/BR112015029987A8/pt not_active Application Discontinuation
-
2015
- 2015-11-27 PH PH12015502674A patent/PH12015502674B1/en unknown
- 2015-11-29 IL IL242833A patent/IL242833B/en active IP Right Grant
- 2015-11-30 CL CL2015003507A patent/CL2015003507A1/es unknown
- 2015-12-09 ZA ZA2015/08983A patent/ZA201508983B/en unknown
-
2018
- 2018-10-11 IL IL262302A patent/IL262302B/en active IP Right Grant
- 2018-12-06 AU AU2018274937A patent/AU2018274937B2/en active Active
-
2019
- 2019-06-06 JP JP2019106371A patent/JP7224242B2/ja active Active
- 2019-06-13 PH PH12019550096A patent/PH12019550096A1/en unknown
-
2020
- 2020-02-07 US US16/784,911 patent/US11911439B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2015003507A1 (es) | Beta-caseína a2 y prevención de inflamación del intestino | |
| IL267681B (en) | Selective grp94 inhibitors and uses thereof | |
| HRP20181742T1 (hr) | Hidroksialkil-supstituirani derivati feniltriazola i njihova uporaba | |
| IL258081B (en) | Benzimidazole history and their use | |
| BR112016012280A2 (pt) | Dispositivo gerador de aerossol e uma cápsula para uso em um dispositivo gerador de aerossol | |
| SI3265448T1 (sl) | Predzdravila riluzola in njihova uporaba | |
| IL247262B (en) | Cannabinoid compositions and uses | |
| CL2016001609A1 (es) | Composiciones farmacéuticas que comprenden azd9291. | |
| HRP20182179T1 (hr) | 2,3-disupstituirani 1-acil-4-amino-1,2,3,4-tetrahidrokonolin derivati i njihova uporaba kao inhibitora bromodomena | |
| MX2017001512A (es) | Compuestos activos hacia bromodominios. | |
| CL2015003704A1 (es) | Péptidos y peptidomiméticos en usos de combinación y tratamientos para la subpoblacion de pacientes con cáncer | |
| DK2996465T3 (da) | Fiskeopdrætsanlæg og anvendelse deraf | |
| IL246221B (en) | Endazoles and their uses | |
| HRP20182134T1 (hr) | Triazinski spoj i njegova upotreba u medicinske svrhe | |
| CL2015002180A1 (es) | Terapia de combinación para el tratamiento de neumonía nosocomial | |
| KR102068915B9 (ko) | 조직 인자 경로 억제제 항체 및 그의 용도 | |
| PL3007687T3 (pl) | Kombinacja pentacyklicznych triterpenów i hydroksytyrozolu oraz jego pochodnych | |
| HRP20181291T1 (hr) | Heterobicikloarilni inhibitori rorc2 i njihova upotreba | |
| CL2015001446A1 (es) | Procedimiento de preparación de albumina humana con nivel de oxigeno disuelto reducido. | |
| PL3331063T3 (pl) | Akumulator i zespół akumulatorowy | |
| PT2968083T (pt) | Composição dentária que compreende quelante e base | |
| PL3064491T3 (pl) | Pochodna sulfonamidowa i jej zastosowanie medyczne | |
| BR112016004943A2 (pt) | aparelho médico e uso | |
| EP2910131A4 (en) | COMPOSITION FOR THE EMERGENCY PREVENTION AND USE THEREOF | |
| IL240701B (en) | Kntc2 peptides and vaccines containing the same |